List of Figures |
Figure 1‑1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2) | 4 |
Figure 1‑2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2) | 4 |
Figure 1‑3: Companies Researched in This Report (1 of 2) | 5 |
Figure 1‑4: Companies Researched in This Report (2 of 2) | 6 |
Figure 1‑5: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (1 of 2) | 7 |
Figure 1‑6: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (2 of 2) | 8 |
Figure 1‑7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2) | 9 |
Figure 1‑8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2) | 10 |
Figure 1‑9: Interventional Cardiology Device Procedures Covered | 11 |
Figure 1‑10: Interventional Cardiology Device Markets Covered | 12 |
Figure 1‑11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2) | 13 |
Figure 1‑12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2) | 14 |
Figure 1‑13: Version History | 15 |
Figure 2‑1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) | 34 |
Figure 2‑2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) | 35 |
Figure 2‑3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) | 36 |
Figure 2‑4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) | 37 |
Figure 2‑5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) | 38 |
Figure 2‑6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) | 39 |
Figure 4‑1: Coronary Stents by Company | 50 |
Figure 4‑2: Coronary Balloon Catheters by Company | 52 |
Figure 4‑3: Interventional Coronary Catheters by Company | 54 |
Figure 4‑4: Interventional Coronary Guidewires by Company | 56 |
Figure 4‑5: Coronary Embolic Protection Devices by Company | 58 |
Figure 4‑6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company | 60 |
Figure 4‑7: Coronary Introducer Sheaths by Company (1 of 2) | 62 |
Figure 4‑8: Coronary Introducer Sheaths by Company (2 of 2) | 63 |
Figure 4‑9: Coronary Vascular Closure Devices by Company | 65 |
Figure 4‑10: Diagnostic Coronary Catheters & Guidewires by Company | 67 |
Figure 4‑11: Coronary Intravascular Ultrasound Devices by Company | 69 |
Figure 4‑12: Coronary Optical Coherence Tomography by Company | 71 |
Figure 4‑13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System | 72 |
Figure 4‑14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm | 72 |
Figure 4‑15: Class 2 Device Recall Cordis Precise Nitinol Stent System | 72 |
Figure 4‑16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System | 73 |
Figure 4‑17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System | 73 |
Figure 4‑18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter | 74 |
Figure 4‑19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter | 74 |
Figure 4‑20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters | 75 |
Figure 4‑21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter | 75 |
Figure 4‑22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter | 75 |
Figure 4‑23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter | 75 |
Figure 4‑24: Class 2 Device Recall MAMBA Flex 135 Microcatheter | 76 |
Figure 4‑25: Class 2 Device Recall MAMBA Microcatheter | 76 |
Figure 4‑26: Class 2 Device Recall Guidezilla II Guide Extension Catheter | 76 |
Figure 4‑27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER | 77 |
Figure 4‑28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter | 77 |
Figure 4‑29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters | 77 |
Figure 4‑30: Class 1 Device Recall 6F Taiga Guiding Catheter | 78 |
Figure 4‑31: Class 2 Device Recall Destination Guiding Sheath | 78 |
Figure 4‑32: Class 2 Device Recall Stingray" Guidewire | 79 |
Figure 4‑33: Class 1 Device Recall TurboHawk Plus | 80 |
Figure 4‑34: Class 1 Device Recall HawkOne | 80 |
Figure 4‑35: Class 2 Device Recall Boston Scientific ROTAPRO | 80 |
Figure 4‑36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM | 80 |
Figure 4‑37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER | 81 |
Figure 4‑38: Class 2 Device Recall | 81 |
Figure 4‑39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification | 81 |
Figure 4‑40: Class 2 Device Recall Prelude Short Sheath Introducer | 82 |
Figure 4‑41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer | 82 |
Figure 4‑42: Class 2 Device Recall Avanti Catheter Sheath Introducer | 82 |
Figure 4‑43: Class 1 Device Recall Flexor CheckFlo Introducer | 82 |
Figure 4‑44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS | 83 |
Figure 4‑45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER | 83 |
Figure 4‑46: Class 1 Device Recall Portico Solo ReCollapsible Access System | 83 |
Figure 4‑47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System | 83 |
Figure 4‑48: Class 2 Device Recall Microintroducer Kit | 84 |
Figure 4‑49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices | 85 |
Figure 4‑50: Class 2 Device Recall AngioSeal Evolution | 85 |
Figure 4‑51: Class 1 Device Recall Imager II 5F Angiographic Catheter | 86 |
Figure 4‑52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter | 87 |
Figure 4‑53: Class 2 Device Recall iLab Polaris MultiModality Guidance System | 87 |
Figure 4‑54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN) | 89 |
Figure 4‑55: RESOLUTE ONYX China Single Arm Study | 89 |
Figure 4‑56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48) | 90 |
Figure 4‑57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System | 90 |
Figure 4‑58: PROMUS PREMIER™ China Post-Approval Study | 91 |
Figure 4‑59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) | 91 |
Figure 4‑60: China Resolute Integrity 34/38 mm Study | 92 |
Figure 4‑61: ILUMIEN IV: OPTIMAL PCI | 92 |
Figure 4‑62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) | 93 |
Figure 4‑63: RESOLUTE ONYX Post-Approval Study (ONYX PAS) | 93 |
Figure 4‑64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V) | 94 |
Figure 4‑65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48) | 94 |
Figure 4‑66: Sirolimus DEB in Coronary Bifurcation Lesions | 95 |
Figure 4‑67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV) | 95 |
Figure 4‑68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF) | 96 |
Figure 4‑69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST) | 96 |
Figure 4‑70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater | 97 |
Figure 4‑71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I) | 97 |
Figure 4‑72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease | 97 |
Figure 4‑73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases | 98 |
Figure 4‑74: FIRE AND ICE II Trial Pilot | 99 |
Figure 4‑75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD) | 99 |
Figure 4‑76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First) | 100 |
Figure 4‑77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI) | 101 |
Figure 4‑78: Pressure Guidewire Comparison | 101 |
Figure 4‑79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2) | 102 |
Figure 4‑80: transShield Embolic Protection System Feasibility Study | 102 |
Figure 4‑81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation | 103 |
Figure 4‑82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis | 103 |
Figure 4‑83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s | 104 |
Figure 4‑84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT) | 104 |
Figure 4‑85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT) | 105 |
Figure 4‑86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD) | 105 |
Figure 4‑87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial | 106 |
Figure 4‑88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF) | 106 |
Figure 4‑89: Application of Vascular Closure Device in Transvenous Cardiac Intervention | 107 |
Figure 4‑90: Comparison of Different Vascular Closure Device in TAVI | 107 |
Figure 4‑91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease | 108 |
Figure 4‑92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE) | 108 |
Figure 4‑93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial | 109 |
Figure 4‑94: Vascular Closure Device in Transcatheter Aortic Valve Replacement | 109 |
Figure 4‑95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) | 110 |
Figure 4‑96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES) | 110 |
Figure 4‑97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System | 111 |
Figure 4‑98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) | 111 |
Figure 4‑99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER) | 112 |
Figure 4‑100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS) | 112 |
Figure 4‑101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP) | 113 |
Figure 4‑102: The OPTIMAL Randomized Controlled Trial | 113 |
Figure 4‑103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite) | 114 |
Figure 4‑104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES) | 114 |
Figure 4‑105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS) | 115 |
Figure 4‑106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB) | 116 |
Figure 4‑107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography | 116 |
Figure 4‑108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM) | 117 |
Figure 4‑109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging | 117 |
Figure 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2) | 123 |
Figure 5‑2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2) | 124 |
Figure 5‑3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M) | 128 |
Figure 5‑4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2) | 139 |
Figure 5‑5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2) | 140 |
Figure 5‑6: SWOT Analysis, Abbott (1 of 2) | 155 |
Figure 5‑7: SWOT Analysis, Abbott (2 of 2) | 156 |
Figure 5‑8: SWOT Analysis, Asahi Intecc | 157 |
Figure 5‑9: SWOT Analysis, Boston Scientific | 158 |
Figure 5‑10: SWOT Analysis, Cordis | 159 |
Figure 5‑11: SWOT Analysis, Cook Medical | 160 |
Figure 5‑12: SWOT Analysis, Medtronic | 161 |
Figure 5‑13: SWOT Analysis, Penumbra | 162 |
Figure 5‑14: SWOT Analysis, Philips | 163 |
Figure 5‑15: SWOT Analysis, Teleflex | 164 |
Figure 5‑16: SWOT Analysis, Terumo | 165 |
Figure 6‑1: Coronary Stent Procedures Covered | 169 |
Figure 6‑2: Coronary Stent Markets Covered | 170 |
Figure 6‑3: Coronary Stent Regions Covered, Global (1 of 2) | 171 |
Figure 6‑4: Coronary Stent Regions Covered, Global (2 of 2) | 172 |
Figure 6‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 176 |
Figure 6‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 178 |
Figure 6‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 179 |
Figure 6‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 180 |
Figure 6‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 181 |
Figure 6‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 182 |
Figure 6‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 183 |
Figure 6‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 184 |
Figure 6‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 185 |
Figure 6‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 186 |
Figure 6‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 187 |
Figure 6‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 188 |
Figure 6‑17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M) | 190 |
Figure 6‑18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M) | 192 |
Figure 6‑19: Total Coronary Stent Market, Global, 2019 – 2029 | 194 |
Figure 6‑20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029 | 195 |
Figure 6‑21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$) | 196 |
Figure 6‑22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M) | 197 |
Figure 6‑23: Bare-Metal Stent Market, Global, 2019 – 2029 | 198 |
Figure 6‑24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029 | 199 |
Figure 6‑25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$) | 200 |
Figure 6‑26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M) | 201 |
Figure 6‑27: Drug-Eluting Stent Market, Global, 2019 – 2029 | 202 |
Figure 6‑28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 | 203 |
Figure 6‑29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$) | 204 |
Figure 6‑30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M) | 205 |
Figure 6‑31: Leading Competitors, Coronary Stent Market, Global, 2022 | 211 |
Figure 7‑1: Coronary Balloon Catheter Procedures Covered | 217 |
Figure 7‑2: Coronary Balloon Catheter Markets Covered | 218 |
Figure 7‑3: Coronary Balloon Catheter Regions Covered, Global (1 of 2) | 219 |
Figure 7‑4: Coronary Balloon Catheter Regions Covered, Global (2 of 2) | 220 |
Figure 7‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 224 |
Figure 7‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 226 |
Figure 7‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 227 |
Figure 7‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 228 |
Figure 7‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 229 |
Figure 7‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 230 |
Figure 7‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 231 |
Figure 7‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 232 |
Figure 7‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 233 |
Figure 7‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 234 |
Figure 7‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 235 |
Figure 7‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 236 |
Figure 7‑17: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 (US$M) | 238 |
Figure 7‑18: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 (US$M) | 240 |
Figure 7‑19: Total Coronary Balloon Catheter Market, Global, 2019 – 2029 | 242 |
Figure 7‑20: Units Sold by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 | 243 |
Figure 7‑21: Average Selling Price by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$) | 244 |
Figure 7‑22: Market Value by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$M) | 245 |
Figure 7‑23: PTCA Balloon Catheter Market, Global, 2019 – 2029 | 246 |
Figure 7‑24: Units Sold by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 | 247 |
Figure 7‑25: Average Selling Price by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$) | 248 |
Figure 7‑26: Market Value by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$M) | 249 |
Figure 7‑27: Specialty Balloon Catheter Market, Global, 2019 – 2029 | 250 |
Figure 7‑28: Units Sold by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 | 251 |
Figure 7‑29: Average Selling Price by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$) | 252 |
Figure 7‑30: Market Value by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$M) | 253 |
Figure 7‑31: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022 | 258 |
Figure 8‑1: Interventional Coronary Catheter Procedures Covered | 263 |
Figure 8‑2: Interventional Coronary Catheter Regions Covered, Global (1 of 2) | 264 |
Figure 8‑3: Interventional Coronary Catheter Regions Covered, Global (2 of 2) | 265 |
Figure 8‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 268 |
Figure 8‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 270 |
Figure 8‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 271 |
Figure 8‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 272 |
Figure 8‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 273 |
Figure 8‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 274 |
Figure 8‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 275 |
Figure 8‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 276 |
Figure 8‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 277 |
Figure 8‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 278 |
Figure 8‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 279 |
Figure 8‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 280 |
Figure 8‑16: Interventional Coronary Catheter Market, Global, 2019 – 2029 | 281 |
Figure 8‑17: Units Sold by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 | 282 |
Figure 8‑18: Average Selling Price by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$) | 283 |
Figure 8‑19: Market Value by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$M) | 284 |
Figure 8‑20: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022 | 289 |
Figure 9‑1: Interventional Coronary Guidewire Procedures Covered | 294 |
Figure 9‑2: Interventional Coronary Guidewire Regions Covered, Global (1 of 2) | 295 |
Figure 9‑3: Interventional Coronary Guidewire Regions Covered, Global (2 of 2) | 296 |
Figure 9‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 299 |
Figure 9‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 301 |
Figure 9‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 302 |
Figure 9‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 303 |
Figure 9‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 304 |
Figure 9‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 305 |
Figure 9‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 306 |
Figure 9‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 307 |
Figure 9‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 308 |
Figure 9‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 309 |
Figure 9‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 310 |
Figure 9‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 311 |
Figure 9‑16: Interventional Coronary Guidewire Market, Global, 2019 – 2029 | 312 |
Figure 9‑17: Units Sold by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 | 313 |
Figure 9‑18: Average Selling Price by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$) | 314 |
Figure 9‑19: Market Value by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$M) | 315 |
Figure 9‑20: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022 | 320 |
Figure 10‑1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2) | 326 |
Figure 10‑2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2) | 327 |
Figure 10‑3: Coronary Embolic Protection Device Market, Global, 2019 – 2029 | 330 |
Figure 10‑4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 | 331 |
Figure 10‑5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$) | 332 |
Figure 10‑6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$M) | 333 |
Figure 10‑7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 | 337 |
Figure 11‑1: Atherectomy and IVL Device Procedures Covered | 343 |
Figure 11‑2: Atherectomy and IVL Device Regions Covered, Global (1 of 2) | 344 |
Figure 11‑3: Atherectomy and IVL Device Regions Covered, Global (2 of 2) | 345 |
Figure 11‑4: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029 | 348 |
Figure 11‑5: Coronary Atherectomy and IVL Procedures by Country, North America, 2019 – 2029 | 350 |
Figure 11‑6: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 351 |
Figure 11‑7: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 352 |
Figure 11‑8: Coronary Atherectomy and IVL Procedures by Country, Western Europe, 2019 – 2029 | 353 |
Figure 11‑9: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 354 |
Figure 11‑10: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 355 |
Figure 11‑11: Coronary Atherectomy and IVL Procedures by Country, Middle East, 2019 – 2029 | 356 |
Figure 11‑12: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 357 |
Figure 11‑13: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 358 |
Figure 11‑14: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 359 |
Figure 11‑15: Coronary Atherectomy and IVL Procedures by Country, Africa, 2019 – 2029 | 360 |
Figure 11‑16: Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 | 361 |
Figure 11‑17: Units Sold by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 | 362 |
Figure 11‑18: Average Selling Price by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$) | 363 |
Figure 11‑19: Market Value by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$M) | 364 |
Figure 11‑20: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022 | 368 |
Figure 12‑1: Coronary Introducer Sheath Procedures Covered | 374 |
Figure 12‑2: Coronary Introducer Sheath Regions Covered, Global (1 of 2) | 375 |
Figure 12‑3: Coronary Introducer Sheath Regions Covered, Global (2 of 2) | 376 |
Figure 12‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 | 380 |
Figure 12‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 | 382 |
Figure 12‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 383 |
Figure 12‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 384 |
Figure 12‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 | 385 |
Figure 12‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 386 |
Figure 12‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 387 |
Figure 12‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 | 388 |
Figure 12‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 389 |
Figure 12‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 390 |
Figure 12‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 391 |
Figure 12‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 | 392 |
Figure 12‑16: Coronary Introducer Sheath Market, Global, 2019 – 2029 | 393 |
Figure 12‑17: Units Sold by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 | 394 |
Figure 12‑18: Average Selling Price by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$) | 395 |
Figure 12‑19: Market Value by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$M) | 396 |
Figure 12‑20: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022 | 402 |
Figure 13‑1: Coronary Vascular Closure Device Procedures Covered | 407 |
Figure 13‑2: Coronary Vascular Closure Device Markets Covered | 408 |
Figure 13‑3: Coronary Vascular Closure Device Regions Covered, Global (1 of 2) | 409 |
Figure 13‑4: Coronary Vascular Closure Device Regions Covered, Global (2 of 2) | 410 |
Figure 13‑5: Total Catheterization Procedures by Region, Global, 2019 – 2029 | 413 |
Figure 13‑6: Catheterization Procedures by Country, North America, 2019 – 2029 | 415 |
Figure 13‑7: Catheterization Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 416 |
Figure 13‑8: Catheterization Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 417 |
Figure 13‑9: Catheterization Procedures by Country, Western Europe, 2019 – 2029 | 418 |
Figure 13‑10: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 419 |
Figure 13‑11: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 420 |
Figure 13‑12: Catheterization Procedures by Country, Middle East, 2019 – 2029 | 421 |
Figure 13‑13: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 422 |
Figure 13‑14: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 423 |
Figure 13‑15: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 424 |
Figure 13‑16: Catheterization Procedures by Country, Africa, 2019 – 2029 | 425 |
Figure 13‑17: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029 (US$M) | 427 |
Figure 13‑18: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 (US$M) | 429 |
Figure 13‑19: Coronary Vascular Closure Device Market, Global, 2019 – 2029 | 432 |
Figure 13‑20: Units Sold by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 | 433 |
Figure 13‑21: Average Selling Price by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$) | 434 |
Figure 13‑22: Market Value by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$M) | 435 |
Figure 13‑23: Invasive VCD Market, Global, 2019 – 2029 | 436 |
Figure 13‑24: Units Sold by Region, Invasive VCD Market, Global, 2019 – 2029 | 437 |
Figure 13‑25: Average Selling Price by Region, Invasive VCD Market, Global, 2019 – 2029 (US$) | 438 |
Figure 13‑26: Market Value by Region, Invasive VCD Market, Global, 2019 – 2029 (US$M) | 439 |
Figure 13‑27: Non-Invasive VCD Market, Global, 2019 – 2029 | 440 |
Figure 13‑28: Units Sold by Region, Non-Invasive VCD Market, Global, 2019 – 2029 | 441 |
Figure 13‑29: Average Selling Price by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$) | 442 |
Figure 13‑30: Market Value by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$M) | 443 |
Figure 13‑31: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022 | 448 |
Figure 14‑1: Diagnostic Catheter and Guidewire Procedures Covered | 454 |
Figure 14‑2: Diagnostic Catheter and Guidewire Markets Covered | 455 |
Figure 14‑3: Diagnostic Catheter and Guidewire Regions Covered, Global (1 of 2) | 456 |
Figure 14‑4: Diagnostic Catheter and Guidewire Regions Covered, Global (2 of 2) | 457 |
Figure 14‑5: Total Diagnostic Catheter and Guidewire Procedures by Segment, Global, 2019 – 2029 | 459 |
Figure 14‑6: Angiography Procedures by Region, Global, 2019 – 2029 | 461 |
Figure 14‑7: Angiography Procedures by Country, North America, 2019 – 2029 | 463 |
Figure 14‑8: Angiography Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 464 |
Figure 14‑9: Angiography Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 465 |
Figure 14‑10: Angiography Procedures by Country, Western Europe, 2019 – 2029 | 466 |
Figure 14‑11: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 467 |
Figure 14‑12: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 468 |
Figure 14‑13: Angiography Procedures by Country, Middle East, 2019 – 2029 | 469 |
Figure 14‑14: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 470 |
Figure 14‑15: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 471 |
Figure 14‑16: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 472 |
Figure 14‑17: Angiography Procedures by Country, Africa, 2019 – 2029 | 473 |
Figure 14‑18: FFR Guidewire Procedures by Region, Global, 2019 – 2029 | 475 |
Figure 14‑19: FFR Guidewire Procedures by Country, North America, 2019 – 2029 | 477 |
Figure 14‑20: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 478 |
Figure 14‑21: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 479 |
Figure 14‑22: FFR Guidewire Procedures by Country, Western Europe, 2019 – 2029 | 480 |
Figure 14‑23: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 481 |
Figure 14‑24: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 482 |
Figure 14‑25: FFR Guidewire Procedures by Country, Middle East, 2019 – 2029 | 483 |
Figure 14‑26: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 484 |
Figure 14‑27 FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 485 |
Figure 14‑28: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 486 |
Figure 14‑29: FFR Guidewire Procedures by Country, Africa, 2019 – 2029 | 487 |
Figure 14‑30: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 (US$M) | 489 |
Figure 14‑31: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 (US$M) | 491 |
Figure 14‑32: Total Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 | 493 |
Figure 14‑33: Units Sold by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 | 494 |
Figure 14‑34: Average Selling Price by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$) | 495 |
Figure 14‑35: Market Value by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$M) | 496 |
Figure 14‑36: Interventional Diagnostic Catheter Market, Global, 2019 – 2029 | 497 |
Figure 14‑37: Units Sold by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 | 498 |
Figure 14‑38: Average Selling Price by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$) | 499 |
Figure 14‑39: Market Value by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$M) | 500 |
Figure 14‑40: Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 | 501 |
Figure 14‑41: Units Sold by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 | 502 |
Figure 14‑42: Average Selling Price by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$) | 503 |
Figure 14‑43: Market Value by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$M) | 504 |
Figure 14‑44: FFR Guidewire Market, Global, 2019 – 2029 | 505 |
Figure 14‑45: Units Sold by Region, FFR Guidewire Market, Global, 2019 – 2029 | 506 |
Figure 14‑46: Average Selling Price by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$) | 507 |
Figure 14‑47: Market Value by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$M) | 508 |
Figure 14‑48: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022 | 514 |
Figure 15‑1: OCT Catheter Procedures Covered | 519 |
Figure 15‑2: OCT Catheter Regions Covered, Global (1 of 2) | 520 |
Figure 15‑3: OCT Catheter Regions Covered, Global (2 of 2) | 521 |
Figure 15‑4: OCT Procedures by Region, Global, 2019 – 2029 | 525 |
Figure 15‑5: OCT Procedures by Country, North America, 2019 – 2029 | 527 |
Figure 15‑6: OCT Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 528 |
Figure 15‑7: OCT Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 529 |
Figure 15‑8: OCT Procedures by Country, Western Europe, 2019 – 2029 | 530 |
Figure 15‑9: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 531 |
Figure 15‑10: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 532 |
Figure 15‑11: OCT Procedures by Country, Middle East, 2019 – 2029 | 533 |
Figure 15‑12: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 534 |
Figure 15‑13: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 535 |
Figure 15‑14: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 536 |
Figure 15‑15: OCT Procedures by Country, Africa, 2019 – 2029 | 537 |
Figure 15‑16: OCT Catheter Market, Global, 2019 – 2029 | 538 |
Figure 15‑17: Units Sold by Region, OCT Catheter Market, Global, 2019 – 2029 | 539 |
Figure 15‑18: Average Selling Price by Region, OCT Catheter Market, Global, 2019 – 2029 (US$) | 540 |
Figure 15‑19: Market Value by Region, OCT Catheter Market, Global, 2019 – 2029 (US$M) | 541 |
Figure 15‑20: Leading Competitors, OCT Catheter Market, Global, 2022 | 545 |
Figure 16‑1: IVUS Catheter Procedures Covered | 550 |
Figure 16‑2: IVUS Catheter Regions Covered, Global (1 of 2) | 551 |
Figure 16‑3: IVUS Catheter Regions Covered, Global (2 of 2) | 552 |
Figure 16‑4: IVUS Procedures by Region, Global, 2019 – 2029 | 555 |
Figure 16‑5: IVUS Procedures by Country, North America, 2019 – 2029 | 557 |
Figure 16‑6: IVUS Procedures by Country, Latin America, 2019 – 2029 (1 of 2) | 558 |
Figure 16‑7: IVUS Procedures by Country, Latin America, 2019 – 2029 (2 of 2) | 559 |
Figure 16‑8: IVUS Procedures by Country, Western Europe, 2019 – 2029 | 560 |
Figure 16‑9: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) | 561 |
Figure 16‑10: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) | 562 |
Figure 16‑11: IVUS Procedures by Country, Middle East, 2019 – 2029 | 563 |
Figure 16‑12: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) | 564 |
Figure 16‑13: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) | 565 |
Figure 16‑14: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) | 566 |
Figure 16‑15: IVUS Procedures by Country, Africa, 2019 – 2029 | 567 |
Figure 16‑16: IVUS Catheter Market, Global, 2019 – 2029 | 568 |
Figure 16‑17: Units Sold by Region, IVUS Catheter Market, Global, 2019 – 2029 | 569 |
Figure 16‑18: Average Selling Price by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$) | 570 |
Figure 16‑19: Market Value by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$M) | 571 |
Figure 16‑20: Leading Competitors, IVUS Catheter Market, Global, 2022 | 575 |